Cargando…
Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response
BACKGROUND: Plasma biomarkers may be particularly useful as a predictor or early marker of clinical response to treatment in addition to radiological imaging. Cytokeratin 18 (CK18) is an epithelial-specific cytokeratin that undergoes cleavage by caspases during apoptosis. Measurement of caspase-clea...
Autores principales: | Scott, L C, Evans, T R J, Cassidy, J, Harden, S, Paul, J, Ullah, R, O'Brien, V, Brown, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720228/ https://www.ncbi.nlm.nih.gov/pubmed/19603019 http://dx.doi.org/10.1038/sj.bjc.6605175 |
Ejemplares similares
-
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
por: Dive, C, et al.
Publicado: (2010) -
Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib
por: Kovac, Rachel L., et al.
Publicado: (2018) -
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis
por: Cha, Seung-Ick, et al.
Publicado: (2012) -
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours
por: Hoh, C K, et al.
Publicado: (2014) -
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
por: Korver, Samantha, et al.
Publicado: (2021)